Clinicopathological Characteristics of Triple-negative Breast Cancers in the Northeast Region of Turkey.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4115936)

Published in Balkan Med J on June 01, 2014

Authors

Bülent Yıldız1, Evren Fidan2, Feyyaz Ozdemir3, Orhan Sezen4, Halil Kavgacı3, Fazıl Aydın3

Author Affiliations

1: Department of Medical Oncology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey.
2: Department of Medical Oncology, Konya Training and Research Hospital, Konya, Turkey.
3: Department of Medical Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.
4: Department of Radiation Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Molecular portraits of human breast tumours. Nature (2000) 94.14

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82

Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68

Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res (2007) 16.79

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol (2008) 11.03

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer (2007) 10.60

Prognostic markers in triple-negative breast cancer. Cancer (2007) 6.28

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer (2005) 3.07

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2008) 2.97

E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res (2003) 2.61

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol (1988) 2.00

Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat (2008) 1.40

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer. BMC Cancer (2008) 1.38

The prognostic importance of triple negative breast carcinoma. Breast (2008) 1.27

Is triple negative a prognostic factor in breast cancer? Breast Cancer (2008) 1.26

Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience. Ann Oncol (2007) 0.92

Epidemiological and clinical profile of triple negative breast cancer at a cancer hospital in North India. Indian J Med Paediatr Oncol (2013) 0.89

Impact of triple-negative breast cancer phenotype on prognosis in patients with stage I breast cancer. J Breast Cancer (2012) 0.88

Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study. Asian Pac J Cancer Prev (2013) 0.85

Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Cancer (2003) 0.82

[Clinical-pathological characteristics and survival of triple negative breast cancer]. Zhonghua Yi Xue Za Zhi (2009) 0.78

[Clinical characteristics comparison between triple-negative and non-triple-negative breast cancer]. Zhonghua Wai Ke Za Zhi (2009) 0.77